Focal Seizures
📧 Sign up to get email alerts when something new happens for Focal Seizures.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: A Safety, Tolerability, and Preliminary Efficacy of Low-intensity Focused Ultrasound Neuromodulation in Patients With Drug-resistant Epilepsy [Phase 1, Phase 2]
NaviFUS Corporation is conducting a Phase 1/2 clinical trial to evaluate the safety, tolerability, and preliminary efficacy of low-intensity…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: A Pilot Study to Evaluate the Efficacy and Safety of NaviFUS™ System Neuromodulating Treatment for Patients With Drug Resistant Epilepsy [NA]
A pilot study to evaluate the efficacy and safety of the NaviFUS System Neuromodulating Treatment for patients with drug-resistant epilepsy …
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: Pivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal Epilepsy [NA]
This update summarizes results from a completed trial evaluating the safety and potential therapeutic impact of transcranial direct current …
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures [Phase 1]
This Phase 1 clinical trial is evaluating the efficacy and safety of Cannabidiol Oral Solution for focal seizures and is currently recruitin…
-
CLINICAL_TRIALS withdrawal · 2025-09-08Clinical Trial Update: EpiCare@Home Validation Study for Focal Onset Seizures [NA]
A clinical trial evaluating EpiCare@Home for focal onset seizures has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-05-31Clinical Trial Update: Double-blind, Randomized Trial of PRAX-628 in Adults With Focal Seizures to Evaluate Efficacy and Safety (POWER1) [Phase 2, Phase 3]
A double-blind, randomized trial evaluating PRAX-628 for efficacy and safety in adults with focal seizures is currently in Phase 2/3 and act…
-
CLINICAL_TRIALS research · 2024-07-23Clinical Trial Update: Thermocoagulation in Drug Resistant Focal Epilepsy [NA]
This ClinicalTrials.gov entry describes a study of thermocoagulation for drug-resistant focal epilepsy; the trial is currently active but no…
-
CLINICAL_TRIALS trial_result · 2022-12-20Clinical Trial Update: A Study of GWP42006 in People With Focal Seizures - Part B [Phase 2]
Phase 2 trial update for GWP42006 in people with focal seizures (epilepsy) has completed.
-
CLINICAL_TRIALS trial_result · 2022-12-20Clinical Trial Update: A Study of GWP42006 in People With Focal Seizures - Part A [Phase 2]
Phase 2 trial update for GWP42006 in people with focal seizures (epilepsy) has been completed.
-
CLINICAL_TRIALS trial_result · 2021-04-27Clinical Trial Update: Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy [Phase 2]
Phase 2 trial investigating natalizumab for focal epilepsy has completed with posted results.
-
CLINICAL_TRIALS withdrawal · 2018-04-30Clinical Trial Update: Turmeric as Treatment in Epilepsy [NA]
A clinical trial evaluating turmeric as a treatment for epilepsy has been withdrawn, including conditions such as Dravet syndrome, Lennox-Ga…
-
CLINICAL_TRIALS trial_result · 2017-09-19Clinical Trial Update: Effect of Carbamazepine and Oxcarbazepine on Serum Neuron-specific Enolase and S100B in Focal Seizures [Phase 4]
A Phase 4 trial assessing how carbamazepine and oxcarbazepine affect serum neuron-specific enolase and S100B in patients with focal seizures…
-
FDA approval · 2014-05-08FDA Approved: TRILEPTAL — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for Trileptal (oxcarbazepine) submitted by Novartis Pharmaceuticals Corporation, resulting in ch…